JP2006506979A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006506979A5 JP2006506979A5 JP2004536574A JP2004536574A JP2006506979A5 JP 2006506979 A5 JP2006506979 A5 JP 2006506979A5 JP 2004536574 A JP2004536574 A JP 2004536574A JP 2004536574 A JP2004536574 A JP 2004536574A JP 2006506979 A5 JP2006506979 A5 JP 2006506979A5
- Authority
- JP
- Japan
- Prior art keywords
- biomarkers
- sample
- symptoms
- osteoarthritis
- expression level
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41018002P | 2002-09-12 | 2002-09-12 | |
| PCT/US2003/029136 WO2004024892A2 (en) | 2002-09-12 | 2003-09-12 | Identification of sequences particularly useful for the diagnosis and identification of therapeutic targets for osteoarthritis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006506979A JP2006506979A (ja) | 2006-03-02 |
| JP2006506979A5 true JP2006506979A5 (https=) | 2006-11-02 |
Family
ID=31994085
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004536574A Pending JP2006506979A (ja) | 2002-09-12 | 2003-09-12 | 変形性関節症のための治療標的の診断および同定に特に有用な配列の同定 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US7452667B2 (https=) |
| EP (1) | EP1581652A4 (https=) |
| JP (1) | JP2006506979A (https=) |
| AU (1) | AU2003272465A1 (https=) |
| CA (1) | CA2495252A1 (https=) |
| WO (1) | WO2004024892A2 (https=) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1668111A4 (en) * | 2003-08-08 | 2008-07-02 | Genenews Inc | OSTEOARTHRITIS BIOMARKERS AND USES THEREOF |
| US20050186577A1 (en) | 2004-02-20 | 2005-08-25 | Yixin Wang | Breast cancer prognostics |
| GB0412301D0 (en) | 2004-06-02 | 2004-07-07 | Diagenic As | Product and method |
| WO2006007664A1 (en) * | 2004-07-22 | 2006-01-26 | Genomics Research Partners Pty Ltd | Agents and methods for diagnosing osteoarthritis |
| EP1782074A2 (en) | 2004-08-18 | 2007-05-09 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Biomarkers for osteoarthritis |
| US7713695B2 (en) * | 2005-02-07 | 2010-05-11 | Genenews, Inc. | Mild osteoarthritis biomarkers and uses thereof |
| US8224579B2 (en) * | 2005-06-17 | 2012-07-17 | The Brigham And Women's Hospital, Inc. | Method of diagnosing osteoarthritis |
| CN103424541B (zh) * | 2006-05-18 | 2018-01-30 | 分子压型学会股份有限公司 | 确定针对病状的个性化医疗介入的系统和方法 |
| US12366585B2 (en) | 2006-05-18 | 2025-07-22 | Caris Mpi, Inc. | Molecular profiling of tumors |
| JP2011117813A (ja) * | 2009-12-02 | 2011-06-16 | Hokuriku Univ | 変形性関節症のマーカーおよびそれを用いた診断 |
| WO2011109738A1 (en) * | 2010-03-05 | 2011-09-09 | The Curators Of The University Of Missouri | Biomarkers of osteoarthritis |
| JP5855849B2 (ja) * | 2010-06-04 | 2016-02-09 | 花王株式会社 | 新規ヒアルロン酸分解促進因子及びその阻害剤 |
| US20150049177A1 (en) * | 2012-02-06 | 2015-02-19 | Biooptico Ab | Camera Arrangement and Image Processing Method for Quantifying Tissue Structure and Degeneration |
| US9034606B2 (en) * | 2012-08-23 | 2015-05-19 | New England Biolabs, Inc. | Detection of an amplification reaction product using pH-sensitive dyes |
| EP3594360B1 (en) | 2014-04-24 | 2021-06-23 | Lucira Health, Inc. | Colorimetric detection of nucleic acid amplification |
| JP6949864B2 (ja) | 2016-03-14 | 2021-10-13 | ルシラ ヘルス インコーポレイテッド | 生物学的アッセイ試料調製および送り出しのための装置および方法 |
| EP3429543B1 (en) | 2016-03-14 | 2024-11-20 | Pfizer Inc. | Selectively vented biological assay devices and associated methods |
| AU2017232340B2 (en) | 2016-03-14 | 2022-04-28 | Pfizer Inc. | Systems and methods for performing biological assays |
| ES2927062T3 (es) | 2016-03-14 | 2022-11-02 | Lucira Health Inc | Dispositivos y procedimientos para modificar propiedades ópticas |
| US11080848B2 (en) | 2017-04-06 | 2021-08-03 | Lucira Health, Inc. | Image-based disease diagnostics using a mobile device |
| CN113777011B (zh) | 2017-09-14 | 2024-11-19 | 辉瑞公司 | 具有电子读出的复用生物测定装置 |
| US10549275B2 (en) | 2017-09-14 | 2020-02-04 | Lucira Health, Inc. | Multiplexed biological assay device with electronic readout |
| USD910200S1 (en) | 2018-12-21 | 2021-02-09 | Lucira Health, Inc. | Test tube |
| USD953561S1 (en) | 2020-05-05 | 2022-05-31 | Lucira Health, Inc. | Diagnostic device with LED display |
| USD962470S1 (en) | 2020-06-03 | 2022-08-30 | Lucira Health, Inc. | Assay device with LCD display |
| KR102466691B1 (ko) * | 2020-06-16 | 2022-11-14 | 한양대학교 에리카산학협력단 | Tsg6 억제제를 포함하는 전이성 고형암 치료용 조성물 |
| CN113249464B (zh) * | 2021-04-13 | 2022-09-27 | 广东省中医院（广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院） | 环状rna作为骨关节炎标志物的应用 |
| CN121227915B (zh) * | 2025-12-01 | 2026-03-06 | 深圳市中医院 | 一种检测膝骨关节炎的探针组合、试剂盒及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7625697B2 (en) * | 1994-06-17 | 2009-12-01 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for constructing subarrays and subarrays made thereby |
| EP0705842A2 (en) * | 1994-10-06 | 1996-04-10 | Hoechst Aktiengesellschaft | Regulated genes by stimulation of chondrocytes with 1L-1beta |
| WO2001053531A2 (en) * | 2000-01-18 | 2001-07-26 | Pharmacia Corporation | Osteoarthritis tissue derived nucleic acids, polypeptides, vectors, and cells |
| JP2004536575A (ja) * | 2001-02-28 | 2004-12-09 | コンドロジーン・インコーポレイテッド | 変形性関節症に関連する組成物および方法 |
-
2003
- 2003-09-12 WO PCT/US2003/029136 patent/WO2004024892A2/en not_active Ceased
- 2003-09-12 US US10/661,242 patent/US7452667B2/en not_active Expired - Fee Related
- 2003-09-12 CA CA002495252A patent/CA2495252A1/en not_active Abandoned
- 2003-09-12 AU AU2003272465A patent/AU2003272465A1/en not_active Abandoned
- 2003-09-12 JP JP2004536574A patent/JP2006506979A/ja active Pending
- 2003-09-12 EP EP03754646A patent/EP1581652A4/en not_active Withdrawn
-
2008
- 2008-05-13 US US12/152,163 patent/US20090048115A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006506979A5 (https=) | ||
| CN113227468A (zh) | 感染性疾病的检测和预测 | |
| US12110556B2 (en) | Kit for assessing the risk of complications in patients with systemic inflammatory response syndrome (SIRS) | |
| EP3356556A2 (en) | A method for diagnosing a disease by detection of circrna in bodily fluids | |
| WO2011008349A2 (en) | Methods of identifying infectious disease and assays for identifying infectious disease | |
| US20210254179A1 (en) | Set of genes for molecular classifying of medulloblastoma and use thereof | |
| AU2020343336A1 (en) | Systems, methods, and compositions for the rapid early-detection of host RNA biomarkers of infection and early identification of COVID-19 coronavirus infection in humans | |
| JP2021523744A (ja) | 脳卒中の血液バイオマーカー | |
| CN107586862A (zh) | 肠道菌群在儿童反复呼吸道感染诊断中的应用 | |
| KR20220030079A (ko) | 전장유전체 증폭을 위한 인간 사스-코로나바이러스-2 범용 프라이머 세트 및 이를 이용한 진단 키트 | |
| JP2008516588A (ja) | 多臓器不全の非感染性原因と感染性原因とを区別するための方法 | |
| WO2015079060A2 (en) | Mirnas as advanced diagnostic tool in patients with cardiovascular disease, in particular acute myocardial infarction (ami) | |
| JP2019524115A (ja) | 気分障害検査用バイオマーカーとしてのｒｎａ編集 | |
| JP2008547006A5 (https=) | ||
| EP2062983A3 (de) | Primer und Sonden zum Nachweis genitaler HPV-Genotypen | |
| CN105838720B (zh) | Ptprq基因突变体及其应用 | |
| KR102721052B1 (ko) | 전장유전체 증폭을 위한 리프트밸리열 바이러스 범용 프라이머 세트 및 이를 이용한 진단 키트 | |
| WO2007056332A3 (en) | Molecular diagnosis of autoimmune diseases | |
| CN109468373A (zh) | 一种与帕金森发生发展相关的生物标志物 | |
| CN115772558A (zh) | 一种用于肝衰竭疾病转归预后评价的试剂盒及应用及应用方法 | |
| US10801066B2 (en) | Determination of risk for development of cardiovascular disease by measuring urinary levels of podocin and nephrin messenger RNA | |
| DE60334408D1 (de) | Nsäuren | |
| CN112458162A (zh) | 器官移植ddcfDNA检测试剂和方法 | |
| CN113444784B (zh) | 重症先天性中性粒细胞减少症检测引物组合物及应用 | |
| CA2960435C (en) | Determination of risk for development of cardiovascular disease by measuring urinary levels of podocin and nephrin messenger rna |